Аналитический обзор факторов риска атеросклероза

В современной медицине изучение механизма атерогенеза является одним из наиболее актуальных направлений. По мере накопления новых знаний о данном процессе возникает необходимость их анализа, переосмысления и дополнения уже имеющихся представлений о патогенезе атеросклероза. Анализ литературных источников позволил выделить шесть классических и две новые теории, которые объясняют возможные причины этого заболевания. Однако эти теории не могут полностью объяснить весь механизм развития атеросклероза, поскольку они рассматривают отдельные его аспекты в соответствии с лежащими в их основе гипотезами. Цель данного обзора литературы — не только систематизировать уже имеющиеся данные, но и попытаться ответить на вопросы, возникающие при изучении отдельных аспектов атерогенеза. В результате анализа было выявлено, что возникновение системного эндотелиита, вызванного различными факторами, такими как бактериальные и вирусные инфекции, а также образование активных радикалов оксида азота и кислорода, могут усугубить процесс, способствуя накоплению и задержке липопротеинов низкой плотности в интиме сосуда. Воспаление приводит к гиперпродукции провоспалительных агентов, которые снижают эффективность утилизации и транспорта холестерина из межклеточного пространства в кровь и лимфатическую систему. Систематизация полученных данных в статье может послужить основой для дальнейших исследований, направленных на определение так называемых «контрольных точек», разработку новых методов мониторинга и выявление информативных маркеров атерогенеза.

1. Lysenkov S.P., Muzhenya D.V., Tuguz A.R., Shumilov D.S. An Integral Focus on the Pathogenesis of Atherosclerosis Based on Modern Data. International Journal of Research Studies in Medical and Health Sciences. 2021;6(5):20-31. DOI: 10.22259/ijrsmhs.0605004

2. Yamaguchi T., Morino K. Perivascular mechanical environment: A narrative review of the role of externally applied mechanical force in the pathogenesis of atherosclerosis. Front. Cardiovasc. Med. 2022;9:944356. DOI: 10.3389/fcvm.2022.944356

3. Weinberg P.D. Haemodynamic Wall Shear Stress, Endothelial Permeability and Atherosclerosis-A Triad of Controversy. Front. Bioeng. Biotechnol. 2022;10:836680. DOI: 10.3389/fbioe.2022.836680

4. Lemole G.M. The importance of the lymphatic system in vascular disease. J. Integr. Cardiol. 2016;2:1-10. DOI: 10.15761/JIC.1000188

5. Batty M., Bennett M.R., Yu E. The role of oxidative stress in atherosclerosis. Cells. 2022;11(23):3843. DOI: 10.3390/cells11233843

6. Gaggini M., Gorini F., Vassalle C. Lipids in atherosclerosis: pathophysiology and the role of calculated lipid indices in assessing cardiovascular risk in patients with hyperlipidemia. Int. J. Mol. Sci. 2022;24(1):75. DOI: 10.3390/ijms24010075

7. Zhang X., Sessa W.C., Fernandez-Hernando C. Endothelial transcytosis of lipoproteins in atherosclerosis. Front. Cardiovasc. Med. 2018;5:130. DOI: 10.3389/fcvm.2018.00130

8. Jang E., Robert J., Rohrer L., von Eckardstein A., Lee W.L. Transendothelial transport of lipoproteins. Atherosclerosis. 2020;315:111-125. DOI: 10.1016/j.atherosclerosis.2020.09.020

9. Goldstein J.L, Brown M.S. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 2009;29(4):431-8. DOI: 10.1161/atvbaha.108.179564

10. Santibanez J.F., Blanco F.J., Garrido-Martin E.M., Sanz-Rodriguez F., del Pozo M.A., Bernabeu C. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae. Cardiovasc. Res. 2008;77(4):791-9. DOI: 10.1093/cvr/cvm097

11. Chistiakov D.A., Bobryshev Y.V., Orekhov A.N. Macrophage-mediated cholesterol handling in atherosclerosis. J. Cell. Mol. Med. 2016;20(1):17-28. DOI: 10.1111/jcmm.12689

12. Vedhachalam C., Ghering A.B., Davidson W.S., Lund-Katz S., Rothblat G.H., Phillips M.C. ABCA1-induced cell surface binding sites for ApoA-I. Arterioscler. Thromb. Vasc. Biol. 2007;27(7):1603-9. DOI: 10.1161/atvbaha.107.145789

13. Nohturfft A., Zhang S.C. Coordination of lipid metabolism in membrane biogenesis. Annu. Rev. Cell. Dev. Biol. 2009;25:539-66. DOI: 10.1146/annurev.cellbio.24.110707.175344

14. Neufeld E.B., Stonik J.A., Demosky S.J. Jr., Knapper C.L., Combs C.A., Cooney A., Comly M., Dwyer N., Blanchette-Mackie J., Remaley A.T., Santamarina-Fojo S., Brewer H.B. Jr. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J. Biol. Chem. 2004;279(15):15571-8. DOI: 10.1074/jbc.m314160200

15. Fung K.Y.Y., Ho T.W.W., Xu Z., Neculai D., Beauchemin C.A.A., Lee W.L., Fairn G.D. Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1. J. Lipid Res. 2024;65(4):100530. DOI: 10.1016/j.jlr.2024.100530

16. Little P.J., Ballinger M.L., Osman N. Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis. Vasc. Health Risk Manag. 2007;3(1):117-24. https://pmc.ncbi.nlm.nih.gov/articles/PMC1994044/

17. Seneff S., Davidson R.M., Lauritzen A., Samsel A., Wainwright G. A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome. Theor. Biol. Med. Model. 2015;12:9. DOI: 10.1186/s12976-015-0006-1

18. Johno H., Yoshimura K., Mori Y., Kimura T., Niimi M., Yamada M., Tanigawa T., Fan J., Takeda S. Detection of potential new biomarkers of atherosclerosis by probe electrospray ionization mass spectrometry. Metabolomics. 2018;14(4):38. DOI: 10.1007/s11306-018-1334-z

19. Milasan A., Dallaire F., Mayer G., Martel C. Effects of LDL Receptor Modulation on Lymphatic Function. Sci. Rep. 2016;6:27862 DOI: 10.1038/srep27862

20. Miyazaki T, Miyazaki A. Hypercholesterolemia and Lymphatic Defects: The Chicken or the Egg? Front. Cardiovasc. Med. 2021;8:701229. DOI: 10.3389/fcvm.2021.701229

21. Laffin L.J., Nissen S.E. Lp(a) - an overlooked risk factor. Trends Cardiovasc. Med. 2024;34(3):193-199. DOI: 10.1016/j.tcm.2023.01.003

22. Unruh D., Srinivasan R., Benson T., Haigh S., Coyle D., Batra N. et al. Red blood cell dysfunction induced by high-fat diet: potential implications for obesity-related atherosclerosis. Circulation. 2015;132(20):1898-908. DOI: 10.1161/circulationaha.115.017313

23. Zheng K., Qian Y., Wang H., Song D., You H., Hou B. et al. Combinatorial lipidomics and proteomics underscore erythrocyte lipid membrane aberrations in the development of adverse cardio-cerebro-vascular complications in maintenance hemodialysis patients. Redox Biol. 2024;78:103389. DOI: 10.1016/j.redox.2024.103389

24. Benson T.W., Weintraub N.L., Kim H.W., Seigler N., Kumar S., Pye J.et al. A single high-fat meal provokes pathological erythrocyte remodeling and increases myeloperoxidase levels: implications for acute coronary syndrome. Lab. Invest. 2018;98(10):1300-1310. DOI: 10.1038/s41374-018-0038-3

25. Raj D.S., Vincent B., Simpson K., Sato E., Jones K.L., Wel-bourne T.C. et al. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int. 2002;61(2):697-704. DOI: 10.1046/j.1523-1755.2002.00150.x

26. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric. Oxide. 2006;15(4):265-79. DOI: 10.1016/j.niox.2006.03.011

27. Montón M., López-Farré A., Mosquera J.R., Sánchez de Miguel L., García-Durán M., Sierra M.P. et al. Endogenous angiotensin II produced by endothelium regulates interleukin-1beta-stimulated nitric oxide generation in rat isolated vessels. Hypertension. 1997;30(5):1191-7. DOI: 10.1161/01.hyp.30.5.1191

28. Lysenkov S.P., Muzhenya D.V., Tuguz A.R., Urakova T.U., Shumilov D.S., Thakushinov I.A. et al. Cholinergic deficiency in the cholinergic system as a pathogenetic link in the formation of various syndromes in COVID-19. Chin. J. Physiol. 2023;66(1):1-13. DOI: 10.4103/cjop.cjop-d-22-00072

29. Qureshi A.A., Khan D.A., Mahjabeen W., Papasian C.J., Qureshi N. Suppression of nitric oxide production and cardiovascular risk factors in healthy seniors and hypercholesterolemic subjects by a combination of polyphenols and vitamins. J. Clin. Exp. Cardiolog. 2012;S5:8. DOI: 10.4172/2155-9880.S5-008

30. Sato I., Yamamoto S., Kakimoto M., Fujii M., Honma K., Kumazaki S.et al. Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism. Pharmacol. Rep. 2022;74(4):669-683. DOI: 10.1007/s43440-022-00380-1

31. Zhang F., Yu W., Hargrove JL., Greenspan P., Dean R.G., Taylor E.W., Hartle D.K. Inhibition of TNF-alpha induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis. 2002;161(2):381-6. DOI: 10.1016/s0021-9150(01)00672-4

32. Stoner L., Lucero A.A., Palmer B.R., Jones L.M., Young J.M., Faulkner J. Inflammatory biomarkers for predicting cardiovascular disease. Clin. Biochem. 2013;46(15):1353-71. DOI: 10.1016/j.clin-biochem.2013.05.070

33. Arabzadeh E., Karimi Nazar N., Gholami M., Roshani Koosha M.S., Zargani M. The effect of eight weeks combined training with omega-3 supplementation on the levels of intercellular adhesion mole-cule-1 and vascular cell adhesion molecule-1 in older women. Clin. Nutr. ESPEN. 2024;61:151-157. DOI: 10.1016/j.clnesp.2024.03.018

34. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2008;54(1):24-38. DOI: 10.1373/clinchem.2007.097360

35. Li H., Cybulsky M.I., Gimbrone M.A Jr., Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 1993;13(2):197-204. DOI: 10.1161/01.atv.13.2.197

36. Tuguz A.R., Shumilov D.S., Muzhenya D.V., Lysenkov S.P., Smolkov I.V., Tatarkova E.A., Khatsats D.Z., Ashkanova T.M. Imbalance of NK cell subpopulations and polymorphisms of proinflammatory cytokine genes in the pathogenesis of atherosclerosis. Medical Immunology (Russia). 2022;24(1):135-146. DOI: 10.15789/1563-0625-ION-2361

37. Niavarani S.R., Lawson C., Bakos O., Boudaud M., Batenchuk C., Rouleau S., Tai L.H. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period. BMC Cancer. 2019;19(1):823.. DOI: 10.1186/s12885-019-6045-y.

38. Warnatsch A., Ioannou M., Wang Q., Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349(6245):316-20. DOI: 10.1126/science.aaa8064

39. Visscher M., Moerman A.M., Burgers P.C., Van Beusekom H.M.M., Luider T.M., Verhagen H.J.M. et al. Data processing pipeline for lipid profiling of carotid atherosclerotic plaque with mass spectrometry imaging. J. Am. Soc. Mass. Spectrom. 2019;30(9):1790-1800. DOI: 10.1007/s13361-019-02254-y

40. Louis S.F., Zahradka P. Vascular smooth muscle cell motility: From migration to invasion. Exp. Clin. Cardiol. 2010;15(4):e75-85. https://pmc.ncbi.nlm.nih.gov/articles/PMC3016065/

41. Bennett M.R., Sinha S., Owens G.K. Vascular smooth muscle cells in atherosclerosis. Circ. Res. 2016;118(4):692-702. DOI: 10.1161/circresaha.115.306361

42. Nidorf S.M., Fiolet A., Abela GS. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability. J. Clin. Lipidol. 2020;14(5):619-630. DOI: 10.1016/j.jacl.2020.07.003

43. Vergallo R., Crea F. Atherosclerotic Plaque Healing. N. Engl. J. Med. 2020;383(9):846-857. DOI: 10.1056/nejmra2000317

44. Lyaker M.R., Tulman D.B., Dimitrova G.T., Pin R.H., Papadimos T.J. Arterial embolism. Int. J. Crit. Illn. Inj. Sci. 2013;3:77-87. DOI: 10.4103/2229-5151.109429

45. Fantuzzi G., Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler. Thromb. Vasc. Biol. 2007;27(5):996-1003. DOI: 10.1161/atvbaha.106.131755

46. von Eynatten M., Schneider J.G. The role of adiponectin in atherosclerosis: do lipids tip the scales? Future Cardiol. 2005;1(6):775-84. DOI: 10.2217/14796678.1.6.775

47. Laurans L., Mouttoulingam N., Chajadine M., Lavelle A., Diedisheim M., Bacquer E.et al. An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the periphery. Cell. Rep. 2023;42(11):113350 DOI: 10.1016/j.celrep.2023.113350

48. Chen L., Ishigami T., D o i H., Arakawa K., Tamura K. Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis. J. Mol. Med. (Berl). 2020;98(9):1235-1244. DOI: 10.1007/s00109-020-01936-5

49. De Nardo D. Toll-like receptors: Activation, signalling and transcriptional modulation. Cytokine. 2015;74(2):181-9. DOI: 10.1016/j.cyto.2015.02.025

50. Roshan M.H., Tambo A., Pace N.P. The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis. Int. J. Infl am. 2016;2016:1532832. DOI: 10.1155/2016/1532832

51. Botts S.R., Fish J.E., Howe K.L. Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment. Front. Pharmacol. 2021;12:787541. DOI: 10.3389/fphar.2021.787541